Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists
- 23 July 2013
- journal article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 50 (5), 1202-1208
- https://doi.org/10.1002/jhet.714
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007
- Diverse mechanisms of antiepileptic drugs in the development pipelineEpilepsy Research, 2006
- Determinants of Ictal Epileptiform Patterns in the Hippocampal SliceEpilepsia, 2002
- New Antiepileptic DrugsArchives of Neurology, 1998
- New antiepileptic drug trials in developing countries: are they necessary?Seizure, 1996
- A Facile Synthesis of Quinoxaline–2,3–diones as NMDA Receptor AntagonistsMolecules, 1996
- Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinonesJournal of Medicinal Chemistry, 1992
- Tricyclic quinoxalines as ligands for the strychnine-insensitive glycine siteBioorganic & Medicinal Chemistry Letters, 1991
- The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure modelsEpilepsy Research, 1991
- 6,7-Dichloroquinoxaline-2,3-Dione is a Competitive Antagonist Specific to Strychnine-Insensitive [3H]Glycine Binding Sites on the N-Methyl-D-Aspartate Receptor ComplexJournal of Neurochemistry, 1990